Neurological disorders are devastating and complex conditions with limited treatment options. By applying our innovative platform technology, we seek to create novel solutions for life-changing therapeutics to patients in medical need.
Our employees are the foundation for the growth and progress of Contera Pharma. We are agile, ambitious and committed to make a difference for patients. We seek synergies in partnerships and collaborations to accomplish our goals.
We are focused on creating a de-risked portfolio of projects aimed at human validated targets. Our scientific capacity and pharma knowledge base serve as strong levers for unraveling both the molecular mechanisms as well as solving the pharmacological challenges in disease.
Contera Pharma A/S
Thomas Sager, CEO
Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for the last 55 years.